Celsis In Vitro Technologies
1450 South Rolling Road
Baltimore
Maryland
21227
United States
Tel: 410-455-1242
Fax: 410-455-1245
Website: http://www.celsis.com/invitro/
Email: info@invitrotech.com
About Celsis In Vitro Technologies
Celsis In Vitro Technologies offers a full range of in vitro products for ADME-Tox applications. Our products reflect our passion for quality, innovation and in many cases, proprietary methods.
- Hepatocytes
- Fresh human and animal hepatocytes
- Cryopreserved human and animal hepatocytes
- Plateable cryopreserved human hepatocytes
- LiverPool™ cryopreserved human hepatocytes
- InVitroGRO™ Media
- Microsomes and S9
- Caco-2.1™ Assay Kits
- Custom Products
Last Updated: 04-23-2007
9 articles about Celsis In Vitro Technologies
-
VistaGen Therapeutics, Inc. Enters Strategic Collaboration With Celsis In Vitro Technologies to Further Advance LiverSafe 3D
3/4/2013
-
Celsis In Vitro Technologies Announces Symposia and Poster Presentations at the 18th North American Regional ISSX Meeting
10/11/2012
-
U.S. Court of Appeals for the Federal Circuit Court Upholds Celsis In Vitro Technologies Injunction Against Life Technologies in LiverPool™ Patent Infringement Lawsuit
1/10/2012
-
Celsis In Vitro Technologies Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool(TM) Patent Infringement Lawsuit
9/13/2010
-
Celsis In Vitro Technologies Seeks Injunction Against Invitrogen Corporation for LiverPool(TM) Patent Infringement
7/1/2010
-
Celsis In Vitro Technologies Finds China Distributor
2/10/2010
-
Celsis In Vitro Technologies and Promega Biosciences, Inc. to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
2/12/2009
-
Celsis In Vitro Technologies Introduces New Assay-Specific Human Liver Microsomes
2/11/2008
-
Celsis International PLC Acquires In Vitro Technologies For $30 Million
8/8/2006